in vitro

Cloning works because even highly differentiated somatic nuclei can de-differentiate and reacquire their ability to form all the cells of the body. The de-differentiation process is driven by egg cytoplasm, and in the 29 September Science Kikyo et al. report that the chromatin remodeling protein ISW1 is probably one component of the de-differentiation machinery (Science 2000, 289:2360-2362). Kikyo et al. identify a number of proteins that are released from permeabilized frog somatic nuclei only

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Cloning works because even highly differentiated somatic nuclei can de-differentiate and reacquire their ability to form all the cells of the body. The de-differentiation process is driven by egg cytoplasm, and in the 29 September Science Kikyo et al. report that the chromatin remodeling protein ISW1 is probably one component of the de-differentiation machinery (Science 2000, 289:2360-2362). Kikyo et al. identify a number of proteins that are released from permeabilized frog somatic nuclei only in the presence of frog egg cytoplasm plus ATP. Fractionation of the egg cytoplasm yields ISW1, a member of the SWI2/SNF2 superfamily of chromatin remodeling proteins. Other chromatin remodeling proteins are not active in the assay, but unidentified proteins are needed in addition to ISW1. Further discoveries in this field may allow for cloning, or the derivation of stem cells, without the need to use egg cells.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies